PDCD1 and neoplasm: This action worked in conjunction with anti-PD-1 treatment, creating a synergistic effect.358 From a mechanistic viewpoint, we discovered that PCSK9 can reduce the presentation of MHC-I on the tumor cell surface by physically interacting with the complex and guiding them towards lysosomal degradation.